Showing results (81-90 of 131) with videos related to

Sort By:
Pageof 14
Abdominal Radiology (New York)|June 22, 2020
Renal biopsies performed before versus during ablation of T1 renal tumors: implications for prevention of overtreatment and follow-upChristiaan V Widdershoven, Brigitte M Aarts, Patricia J Zondervan, et al.
Annals of Surgery|January 15, 2026
Impact of Celiac Axis Stenosis in Patients Undergoing Pancreatoduodenectomy and Total Pancreatectomy: International Multicenter StudyRiccardo Guastella, Giampaolo Perri, Otto M van Delden, et al.
Liver Cancer|October 12, 2019
Body Composition Is an Independent Predictor of Outcome in Patients with Hepatocellular Carcinoma Treated with SorafenibTim A Labeur, Jeroen L A van Vugt, David W G Ten Cate, et al.
Journal of Vascular and Interventional Radiology : JVIR|March 29, 2022
Outcomes of Irreversible Electroporation for Perihilar Cholangiocarcinoma: A Prospective Pilot StudyLotte C Franken, Eran van Veldhuisen, Alette H Ruarus, et al.
Journal of the American Academy of Dermatology|May 17, 2011
Chronic pulmonary embolism in Klippel-Trenaunay syndromeRenée A Douma, Charlène E U Oduber, Victor E A Gerdes, et al.
BMC Cancer|April 18, 2015
The efficacy and safety of irreversible electroporation for the ablation of renal masses: a prospective, human, in-vivo study protocolPeter G K Wagstaff, Daniel M de Bruin, Patricia J Zondervan, et al.
Acta Oncologica (Stockholm, Sweden)|June 27, 2018
Are we SHARP enough? The importance of adequate patient selection in sorafenib treatment for hepatocellular carcinomaTim A Labeur, David W G Ten Cate, R Bart Takkenberg, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|November 24, 2017
The clinical benefit of hyperthermia in pancreatic cancer: a systematic reviewAstrid van der Horst, Eva Versteijne, Marc G H Besselink, et al.
Pageof 14